Anavex Life Sciences
Price & Volume
Stats
See more52W Range | $2.86-$13.99 |
Market Cap | $410.5M |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.46 |
News
See moreYahoo Finance • 15 days ago
3 Promising Penny Stocks With At Least $200M Market Cap
Yahoo Finance • 25 days ago
Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026
Yahoo Finance • 2 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
Yahoo Finance • 2 months ago
Anavex asks EMA to re-examine its negative opinion on blarcamesine for Alzheimer's
About
CEO | Dr. Christopher U. Missling M.B.A., M.S., Ph.D. |
Address | 630 5th Avenue, New York, NY, United States, 10111 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 34 |
